PE20010692A1 - Peptidos modificados y peptidomimeticos para el uso en inmunoterapia - Google Patents

Peptidos modificados y peptidomimeticos para el uso en inmunoterapia

Info

Publication number
PE20010692A1
PE20010692A1 PE2000001107A PE0011072000A PE20010692A1 PE 20010692 A1 PE20010692 A1 PE 20010692A1 PE 2000001107 A PE2000001107 A PE 2000001107A PE 0011072000 A PE0011072000 A PE 0011072000A PE 20010692 A1 PE20010692 A1 PE 20010692A1
Authority
PE
Peru
Prior art keywords
amino acids
alkyl
substitution
ser
amida
Prior art date
Application number
PE2000001107A
Other languages
English (en)
Spanish (es)
Inventor
Anna Maria Helena Boots
Cornelis Marius Timmers
Staveren Catherina Joanna Van
Galen Philippus Johannes Marie Van
Ronald Marcellus Alphonsun Knegtel
Andreas Martinus Maria Miltenburg
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20010692A1 publication Critical patent/PE20010692A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2000001107A 1999-10-18 2000-10-17 Peptidos modificados y peptidomimeticos para el uso en inmunoterapia PE20010692A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203427 1999-10-18

Publications (1)

Publication Number Publication Date
PE20010692A1 true PE20010692A1 (es) 2001-07-06

Family

ID=8240756

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001107A PE20010692A1 (es) 1999-10-18 2000-10-17 Peptidos modificados y peptidomimeticos para el uso en inmunoterapia

Country Status (23)

Country Link
EP (1) EP1226167A1 (tr)
JP (1) JP2003512388A (tr)
KR (1) KR20020047245A (tr)
CN (1) CN1379786A (tr)
AR (1) AR026068A1 (tr)
AU (1) AU780238B2 (tr)
BR (1) BR0014803A (tr)
CA (1) CA2386398A1 (tr)
CO (1) CO5271650A1 (tr)
CZ (1) CZ20021356A3 (tr)
HK (1) HK1046693A1 (tr)
HU (1) HUP0203504A3 (tr)
IL (1) IL148778A0 (tr)
MX (1) MXPA02003520A (tr)
NO (1) NO20021763L (tr)
NZ (1) NZ518256A (tr)
PE (1) PE20010692A1 (tr)
PL (1) PL354590A1 (tr)
RU (1) RU2002113107A (tr)
SK (1) SK6842002A3 (tr)
TR (1) TR200201036T2 (tr)
WO (1) WO2001029081A1 (tr)
ZA (1) ZA200202577B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951212A0 (en) * 2002-09-04 2002-09-19 Monash University A method of modulating cellular activity and molecules for use therein
AU2007235305A1 (en) * 2006-04-06 2007-10-18 Purdue Research Foundation Derivatization-enhanced analysis of amino acids and peptides
EP2114462B1 (en) * 2006-12-21 2013-06-05 Universite De Geneve Compounds for fluorescence imaging
WO2009092381A1 (en) 2008-01-23 2009-07-30 Herlev Hospital, Region Hovedstaden Ykl-40 as a general marker for non-specific disease
WO2010028658A1 (en) 2008-09-15 2010-03-18 Herlev Hospital, Region Hovedstaden Ykl-40 as a marker for gastrointestinal cancers
TWI777260B (zh) 2014-11-07 2022-09-11 美商奇尼塔慢性疼痛有限責任公司 芋螺毒素(conotoxin)肽之修飾及用途
EP3466963A1 (en) * 2017-10-05 2019-04-10 Suigeneris Farmacosmetics, S.L. Anticancer peptides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
IL120561A0 (en) * 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
CN1130372C (zh) * 1996-06-07 2003-12-10 曾尼卡有限公司 肽衍生物
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them

Also Published As

Publication number Publication date
HUP0203504A3 (en) 2005-03-29
ZA200202577B (en) 2003-09-23
NZ518256A (en) 2004-01-30
PL354590A1 (en) 2004-01-26
CZ20021356A3 (cs) 2002-07-17
EP1226167A1 (en) 2002-07-31
HUP0203504A2 (hu) 2003-04-28
NO20021763D0 (no) 2002-04-15
BR0014803A (pt) 2002-06-11
HK1046693A1 (zh) 2003-01-24
WO2001029081A1 (en) 2001-04-26
AU1139601A (en) 2001-04-30
IL148778A0 (en) 2002-09-12
JP2003512388A (ja) 2003-04-02
AR026068A1 (es) 2002-12-26
NO20021763L (no) 2002-04-15
RU2002113107A (ru) 2004-01-10
CO5271650A1 (es) 2003-04-30
TR200201036T2 (tr) 2002-08-21
KR20020047245A (ko) 2002-06-21
CA2386398A1 (en) 2001-04-26
AU780238B2 (en) 2005-03-10
CN1379786A (zh) 2002-11-13
MXPA02003520A (es) 2002-08-20
SK6842002A3 (en) 2002-09-10

Similar Documents

Publication Publication Date Title
PE20120914A1 (es) Compuestos glucagon activo de receptor de gip
BR0114630A (pt) Secretagogos de hormÈnio do crescimento
PE20090108A1 (es) Coagonistas del receptor de glucagon/glp-1
ES2194224T3 (es) Uso de analogos y derivados de glp-1 administrados perifericamente para la regulacion de la obesidad.
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
CY1113850T1 (el) Νεα παραγωγα ινσουλινης
BRPI0517493A (pt) polinucleotìdeo isolado, promotor vetor de expressão, célula hospedeira e uso de um polinucleotìdeo
PE20010692A1 (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia
MX2009012675A (es) Tensioactivos reconstituidos que tienen propiedades mejoradas.
ES8105698A1 (es) Procedimiento para la obtencion de octapeptidos ciclicos
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
EP2189471A4 (en) PEPTIDE FOXM1 AND MEDICINAL AGENT COMPRISING SAME
PE20211466A1 (es) Analogos de proteina tirosina-tirosina y metodos de uso de esta
MX9302475A (es) Polipeptido de origen no natural que tiene la actividad del factor recombinante de estimulacion del receptor neu y proceso para la produccion del mis mo.
MX2009010965A (es) Péptidos de tem8 y vacunas que los contienen.
MX2021010404A (es) Anticuerpos que se unen a una forma escindida de calreticulina mutante, y agente de diagnostico, preventivo o terapeutico para las neoplasias mieloproliferativas.
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
AR008094A1 (es) Proceso para la sintesis de un polipeptido sintetico analogo a la hormona paratiroidea o al peptido relacionado con la hormona paratiroidea y procesopara la preparacion de una composicion farmaceutica.
MX2022004598A (es) Compuestos inmunogenicos para el tratamiento del cancer suprarrenal.
TW200517400A (en) Antagonistic analogs of GH-RH (2003)
PE20040705A1 (es) Polipeptido t20 pegilado
TW200611706A (en) Cytotoxic t lymphocyte
ES2062521T3 (es) Peptidos sinteticos para una vacuna contra hiv-1.
SI1442059T1 (sl) Analogi hormona, ki pospešujejo izločanje rastnega hormona, njihova priprava in uporaba
MY126118A (en) Somatostatin analogs for the treatment of cancer

Legal Events

Date Code Title Description
FD Application declared void or lapsed